Industry News
Cook's MD named health and pharma executive of the year
Managing director of Cook Australia and AusBiotech member Barry Thomas has been named the 2013 'Health and Pharmaceutical Executive of the Year' by The CEO Magazine. The Executive of the Year Awards, held last week in Sydney, recognise individual excellence of high-level executives and the contributions they have made to their companies. [ + ]
Minomic seeks to set prostate cancer test standard
Sydney biotech Minomic aims to commercialise a new prostate cancer test in Australia in 2015-16 and hopes it will become the new diagnostic standard within five years. [ + ]
A new listing for Cynata Therapeutics
Cynata Therapeutics has been backdoored into EcoQuest's shell and reborn on the ASX. [ + ]
Wine's microorganisms analysed through metagenomics
The Australian Wine Research Institute (AWRI) and UNSW's Ramaciotti Centre for Genomics have entered into a research partnership to analyse the microorganisms in their ferments. [ + ]
Ascend and 3M to collaborate on cancer vaccine
US multinational 3M Drug Delivery Systems has partnered with Melbourne-based immunotherapy biotech Ascend Biopharmaceuticals to work on cancer vaccines targeting solid tumour types which incorporate aspects of both companies' technology. [ + ]
Alchemia cleared to continue HA-Irinotecan trial
The DSMB monitoring Alchemia's (ASX:ACL) phase III trial of HA-Irinotecan in metastatic colorectal cancer has, for the fourth time, recommended that the trial continue. [ + ]
Bioniche to delist from ASX
Dual-listed Bioniche (ASX:BNC) has entered negotiations to sell off its animal health division and plans to withdraw from trading on the ASX in 1H14. [ + ]
Science talk at Sydney's Royal Botanic Garden
The Royal Botanic Gardens and Domain Trust is hosting a talk on plant conservation at the Royal Botanic Garden Sydney on 9 December. [ + ]
Fred Hollows Foundation and International Diabetes Federation to tackle diabetic blindness
The Fred Hollows Foundation has signed up to a 10-year partnership with the International Diabetes Federation to tackle a complication of the disease that can lead to blindness. The agreement was announced just days before the start of the World Congress on Diabetes in Melbourne, to be attended by over 10,000 delegates and 400 exhibitors from 2-6 December. [ + ]
Biotron's BIT225 could work in all HCV strains
Independent research published in a scientific journal suggests that Biotron's (ASX:BIT) BIT225 drug candidate shows activity in all six major strains of hepatitis C. [ + ]
Rheology Solutions offers free instrument testing
Rheology Solutions is offering free access to its testing laboratory and rheological technical staff during the months of December 2013 and January 2014. Anyone putting together budget allocations for viscometers or rheometers is invited to contact the company to book their lab time. [ + ]
Clarity, Viralytics get new board members
Clarity Pharmaceuticals has selected a new executive chairman, while fellow Sydney biotech Viralytics (ASX:VLA) has appointed a melanoma expert to its scientific advisory board. [ + ]
New treatment for osteoporosis
A compound that stimulates bone formation in animal models holds promise as a new type of medicine for osteoporosis. [ + ]
Biotech Christmas celebrations kick off next week
State-by-state Christmas celebrations start next week, with Western Australia the first to host AusBiotech's free Christmas event as their final networking event of 2013. The AusBiotech branch committee in each state is pleased to invite AusBiotech members to the end-of-year celebration in thanks for their support throughout 2013. [ + ]
Industry body awards crop scientist
The prestigious 2013 CropLife President's award has been given to Dr Yolanda Gaspar, from the La Trobe Institute for Molecular Science, for her contribution to Australia's $1.5 billion plant science industry. [ + ]
